Regulatory pathway · all topics

510(k) Premarket Notification

A 510(k) clearance under 21 CFR Part 807 Subpart E demonstrates substantial equivalence to a legally marketed predicate device. Required for most Class II devices. Average FDA review time was 177 days in FY2024. Submission must include device description, intended use, predicate comparison, performance data, sterilization, biocompatibility, electrical safety, and software documentation per IEC 62304 if applicable.

Source

FDA Center for Devices and Radiological Health, '510(k) Program: Evaluating Substantial Equivalence' (2014, updated)

https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k

How MedTek OS handles this

Compass drafts the 510(k) premarket notification workflow with confidence-gated content.

The platform refuses to generate content below the threshold for this artifact class. Every claim carries a citation chain back to RIG, audit-logged with HMAC integrity.

Try the sandbox Ask the agent about this

Related pathways

Predicate Device Selection for 510(k)

A predicate device must be legally marketed in the US, not subject to PMA, and not removed from the market for safety or effectiveness reaso...

FDA Device Classification (Class I, II, III)

FDA classifies medical devices into three risk-based classes under 21 CFR Parts 862-892. Class I (~47% of devices, low risk): general contro...

De Novo Classification Request

De Novo creates a new classification for a novel low-to-moderate risk device with no valid predicate. Submission under 21 CFR Part 860 Subpa...

Premarket Approval (PMA)

PMA is the most stringent FDA pathway, required for Class III devices that support or sustain human life or pose significant risk. Filed und...